Atlas Trials

A Randomised, Parallel-group, Double-blind, Double-dummy Study to Compare the Effects of Lacidipine Versus Bendrofluazide on Markers of Platelet Activation and Haemorheological Factors in Hypertensive Patients

Clinical trial NCT02235402 · COMPLETED

Trial details

NCT number
NCT02235402
Sponsor
Boehringer Ingelheim
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Hypertension
Start date
1997-12-01
Primary completion
2000-03-01
Enrollment
26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.